Literature DB >> 14661682

Treatment of brain metastases from melanoma.

Robert R McWilliams1, Paul D Brown, Jan C Buckner, Michael J Link, Svetomir N Markovic.   

Abstract

Brain metastases from malignant melanoma have a poor prognosis, and treatment can be difficult because of rapid progression of the disease. To help define the treatment of this disease, we reviewed the published literature on brain metastases from melanoma. If a solitary metastasis is present, surgery might be beneficial, especially if systemic disease is absent. Stereotactic radiosurgery is a less invasive, attractive option for solitary or oligometastatic (up to 6) lesions. External beam whole-brain radiation therapy can produce responses and frequently palliates symptoms, but as the sole therapy, it is unlikely to eradicate brain metastases. Chemotherapy may be gaining a role with newer agents that penetrate the blood-brain barrier. Combined modality therapy appears to be the future direction of treatment of multiple metastases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661682     DOI: 10.4065/78.12.1529

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  11 in total

1.  Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

Authors:  John L Joyal; John A Barrett; John C Marquis; Jianqing Chen; Shawn M Hillier; Kevin P Maresca; Marie Boyd; Kenneth Gage; Sridhar Nimmagadda; James F Kronauge; Matthias Friebe; Ludger Dinkelborg; James B Stubbs; Michael G Stabin; Rob Mairs; Martin G Pomper; John W Babich
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?

Authors:  Gautham Gampa; Shruthi Vaidhyanathan; Jann N Sarkaria; William F Elmquist
Journal:  Pharmacol Res       Date:  2017-06-17       Impact factor: 7.658

Review 3.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

4.  Challenges in the delivery of therapies to melanoma brain metastases.

Authors:  Gautham Gampa; Shruthi Vaidhyanathan; Brynna-Wilken Resman; Karen E Parrish; Svetomir N Markovic; Jann N Sarkaria; William F Elmquist
Journal:  Curr Pharmacol Rep       Date:  2016-11-09

5.  Determinants of survival in patients with brain metastases from cutaneous melanoma.

Authors:  M Staudt; K Lasithiotakis; U Leiter; F Meier; T Eigentler; M Bamberg; M Tatagiba; P Brossart; C Garbe
Journal:  Br J Cancer       Date:  2010-04-06       Impact factor: 7.640

Review 6.  The Treatment of Melanoma Brain Metastases.

Authors:  Nour Kibbi; Harriet Kluger
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

7.  Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?

Authors:  Carolin Gramsch; Sophia L Göricke; Felix Behrens; Lisa Zimmer; Dirk Schadendorf; Andrej Krasny; Michael Forsting; Marc U Schlamann
Journal:  Eur Radiol       Date:  2013-05-14       Impact factor: 5.315

8.  Improved detection of metastatic melanoma by T2*-weighted imaging.

Authors:  P Gaviani; M E Mullins; T A Braga; E T Hedley-Whyte; E F Halpern; P S Schaefer; J W Henson
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 9.  Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.

Authors:  Minjee Kim; Sani H Kizilbash; Janice K Laramy; Gautham Gampa; Karen E Parrish; Jann N Sarkaria; William F Elmquist
Journal:  Pharm Res       Date:  2018-07-12       Impact factor: 4.200

Review 10.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.